Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
gptkb:170277-31-3
|
| gptkbp:developedBy |
gptkb:Merck
|
| gptkbp:drugClass |
recombinant human growth hormone
ghrelin receptor agonist |
| gptkbp:hasInChIKey |
QZJTYWZEBPJYTH-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C27H36N4O5S
|
| gptkbp:hasSMILES |
CC(C)CN(C)CCCN=C(N)NCC1=CC=CC=C1C(=O)NC2=CC=CC=C2S(=O)(=O)C
|
| gptkbp:hasUNII |
QX8X9C6UFZ
|
| https://www.w3.org/2000/01/rdf-schema#label |
170277-31-3
|
| gptkbp:IUPACName |
2-amino-N-[(2R)-1-(1,3-benzothiazol-2-yl)-2-methylpropyl]-2-methylpropanamide
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:molecularWeight |
528.66 g/mol
|
| gptkbp:otherName |
gptkb:Ibutamoren
gptkb:MK-677 |
| gptkbp:PubChem_CID |
159633
140181 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:infliximab
|
| gptkbp:bfsLayer |
6
|